# BRAIN Biotech AG

> BRAIN Biotech AG is a VC fund in Zwingenberg backing Medical and Biopharma. See 2 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Zwingenberg, Germany
- Total investments: 2
- Last investment: Mar 2023
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/brainbiotech
- X (Twitter): https://twitter.com/brainbiotech
- Website: https://www.brain-biotech.com

BRAIN Biotech AG is a VC fund in Zwingenberg focused on Medical and Biopharma. As industrial biotechnology specialists, BRAIN Biotech develops and produces enzymes, proteins, microbial production strains and bioactive natural products for industrial applications. In addition, the company´s innovative biosolutions help make industrial processes more sustainable. The company focuses on food & beverages, life science, andenvironmental topics. BRAIN Biotech AG is the parent company of the BRAIN Biotech Group and has been listed on the Prime Standard of the Frankfurt Stock Exchange since 9 February 2016 (ticker symbol: BNN).

## Contacts

5 contacts available for BRAIN Biotech AG. Shizune tracks 3 team members at BRAIN Biotech AG. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/brain?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 50% |
| Biopharma | 1 | 50% |
| Health Care | 1 | 50% |
| Biotechnology | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Series B | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Erik de Vries | Sr Director Business Development | 0 | — |
| Ludger Roedder | Chief Business Officer | 0 | — |
| Manfred Bender | Chief Financial Officer | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| SolasCure | SolasCure aims to support healthcare professionals with wound care products that significantly improve the health and wellbeing of patients with chronic wounds. | $13.4M | Series B | Mar 27, 2023 |  |
| SolasCure | SolasCure aims to support healthcare professionals with wound care products that significantly improve the health and wellbeing of patients with chronic wounds. | $20.8M | Series A | Aug 09, 2021 |  |

2 of 2 investments shown.

## Co-investors
- Eva Pharma — VC Fund, 2 deals together
- [Seneca Partners](https://shizune.co/investors/profile/seneca-partners-aa41) — VC Fund, 2 deals together
- [Development Bank of Wales](https://shizune.co/investors/profile/development-bank-of-wales) — VC Fund, 1 deal together
- [Bionova Capital](https://shizune.co/investors/profile/hovione-capital) — VC Fund, 1 deal together
- [Wealth Club](https://shizune.co/investors/profile/wealth-club) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does BRAIN Biotech AG invest in?

BRAIN Biotech AG invests primarily in Medical, Biopharma and Health Care startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact BRAIN Biotech AG?

Public channels for BRAIN Biotech AG include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at BRAIN Biotech AG?

The team at BRAIN Biotech AG includes Erik de Vries (Sr Director Business Development), Ludger Roedder (Chief Business Officer) and Manfred Bender (Chief Financial Officer). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co